Although several clinical trials utilizing the adeno-associated virus (AAV) type 2 serotype 2 (2/2) are now underway, it is unclear whether this particular serotype offers any advantage over others in terms of safety or efficiency when delivered directly to the CNS.
Recombinant AAV2–green fluorescent protein (GFP) serotypes 2/1, 2/2, 2/5, and 2/8 were generated following standard triple transfection protocols (final yield 5.4 × 1012 particles/ml). A total of 180 μl of each solution was stereotactically infused, covering the entire rostrocaudal extent of the caudoputamen in 4 rhesus monkeys (Macaca mulatta) (3.0 ± 0.5 kg). After 6 weeks' survival, the brain was formalin fixed, cut at 40 μm, and stained with standard immunohistochemistry for anti-GFP, anticaspase-2, and cell-specific markers (anti–microtubule-associated protein-2 for neurons and anti–glial fibrillary acidic protein for glia). Unbiased stereological counting methods were used to determine cell number and striatal volume.
The entire striatum of each animal contained GFP-positive cells with significant labeling extending beyond the borders of the basal ganglia. No ischemic/necrotic, hemorrhagic, or neoplastic change was observed in any brain. Total infusate volumes were similar across the 4 serotypes. However, GFP-labeled cell density was markedly different. Adeno-associated virus 2/1, 2/2, and 2/5 each labeled < 8000 cells/mm3, whereas serotype 8 labeled > 21,000 cells, a 3- to 4-fold higher transduction efficiency. On the other hand, serotype 8 also labeled neurons and glia with equal affinity compared with neuronal specificities > 89% for the other serotypes. Moderate caspase-2 colabeling was noted in neurons immediately around the AAV2/1 injection tracts, but was not seen above the background anywhere in the brain following injections with serotypes 2, 5, or 8.
Intrastriatal delivery of AAV2 yields the highest cell transduction efficiencies but lowest neuronal specificity for serotype 8 when compared with serotypes 1, 2, and 5. Only AAV2/1 revealed significant caspase-2 activation. Careful consideration of serotype-specific differences in AAV2 neurotropism, transduction efficiency, and potential toxicity may affect future human trials.
* Drs. Sanchez and Tierney contributed equally to this work.
Address correspondence to: Bob S. Carter, M.D., Ph.D., Department of Neurosurgery, University of California, San Diego, 200 West Arbor Drive, Mail Code 8893, San Diego, California 92103. email: email@example.com.
Please include this information when citing this paper: published online October 15, 2010; DOI: 10.3171/2010.8.JNS091583.
BankiewiczKSEberlingJLKohutnickaMJagustWPivirottoPBringasJ: Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach. Exp Neurol164:2–142000
BroekmanMLComerLAHymanBTSena-EstevesM: Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain. Neuroscience138:501–5102006
BurgerCGorbatyukOSVelardoMJPedenCSWilliamsPZolotukhinS: Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol Ther10:302–3172004
HadaczekPKohutnickaMKrauzeMTBringasJPivirottoPCunninghamJ: Convection-enhanced delivery of adeno-associated virus type 2 (AAV2) into the striatum and transport of AAV2 within monkey brain. Hum Gene Ther17:291–3022006
HamiltonJFMorrisonPFChenMYHarvey-WhiteJPernauteRSPhillipsH: Heparin coinfusion during convection-enhanced delivery (CED) increases the distribution of the glial-derived neurotrophic factor (GDNF) ligand family in rat striatum and enhances the pharmacological activity of neurturin. Exp Neurol168:155–1612001
HardingTCDickinsonPJRobertsBNYendluriSGonzalez-EdickMLecouteurRA: Enhanced gene transfer efficiency in the murine striatum and an orthotopic glioblastoma tumor model, using AAV-7- and AAV-8-pseudotyped vectors. Hum Gene Ther17:807–8202006
KaplittMGFeiginATangCFitzsimonsHLMattisPLawlorPA: Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet369:2097–21052007
LawlorPABlandRJMouravlevAYoungDDuringMJ: Efficient gene delivery and selective transduction of glial cells in the mammalian brain by AAV serotypes isolated from nonhuman primates. Mol Ther17:1692–17022009
MarksWJJrOstremJLVerhagenLStarrPALarsonPSBakayRA: Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial. Lancet Neurol7:400–4082008
McBrideJLBoudreauRLHarperSQStaberPDMonteysAMMartinsI: Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc Natl Acad Sci U S A105:5868–58732008
RabinowitzJERollingFLiCConrathHXiaoWXiaoX: Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J Virol76:791–8012002
SanchezCEGaleJTierneyTSMulliganRCCarterBS: AAV2-mediated gene delivery to the non-human primate striatum: development of a multi-catheter injection system for reproducible single-measure intraoperative convection enhanced delivery. Presented at the Annual Meeting of the Congress of Neurological SurgeonsOrlando, FloridaSeptember 20–25, 2008(Poster) (http://2008.cns.org/posterbrowser.aspx) [Accessed August 24 2010]
TierneyTSPradillaGWangPPClatterbuckRETamargoRJ: Intracranial delivery of the nitric oxide donor diethylenetriamine/ nitric oxide from a controlled-release polymer: toxicity in cynomolgus monkeys. Neurosurgery58:952–9602006
WorgallSSondhiDHackettNRKosofskyBKekatpureMVNeyziN: Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adenoassociated virus expressing CLN2 cDNA. Hum Gene Ther19:463–4742008